Diversified Healthcare Trust (DHC)

NASDAQ: DHC · IEX Real-Time Price · USD
2.460
+0.050 (2.07%)
At close: Mar 28, 2024, 4:00 PM
2.420
-0.040 (-1.63%)
After-hours: Mar 28, 2024, 6:19 PM EDT

Company Description

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States.

DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.

As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units.

DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate.

DHC is headquartered in Newton, MA.

Diversified Healthcare Trust
Diversified Healthcare Trust logo
Country United States
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 600
CEO Christopher J. Bilotto

Contact Details

Address:
C/o The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300
Newton, Massachusetts 02458
United States
Phone (617) 796-8350
Website dhcreit.com

Stock Details

Ticker Symbol DHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001075415
CUSIP Number 25525P107
ISIN Number US25525P1075
Employer ID 04-3445278
SIC Code 6798

Key Executives

Name Position
Adam David Portnoy Managing Chair of the Board
Christopher J. Bilotto President and Chief Executive Officer
Matthew C. Brown Chief Financial Officer and Treasurer
Michael B. Kodesch Director of Investor Relations
David M. Blackman Director of Acquisition
Jennifer Babbin Clark Secretary
Melissa Mccarthy Manager of Investor Relations

Latest SEC Filings

Date Type Title
Mar 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 26, 2024 DEF 14A Other definitive proxy statements
Mar 26, 2024 ARS Filing
Mar 1, 2024 POSASR Filing
Feb 26, 2024 10-K Annual Report
Feb 26, 2024 8-K Current Report
Feb 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals